A platform from 2460 Health TechVisit 2460.life
The Briefing

Meira Briefing

Week of June 29, 2026

Vol. 1 · Issue 5

Here's what happened this week.

1

New case study tackles the ethical gray zone of premortem heparin in DCD donors.

Published July 2, this analysis digs into the ethics of administering heparin before circulatory death in DCD cases - a practice that improves organ viability but raises consent and non-maleficence questions. It offers a framework for weighing donor benefit against the timing of the intervention. Expect this to fuel conversations with hesitant ICU teams and ethics committees.
On your shift: If you've ever hit friction from an OR or ICU staffer over the heparin timing on a DCD case, this gives you the current ethical language to back your protocol.

Source: PubMed (Organ Donation Research)

2

Multicenter apnea testing study links methodology to safety and duration in brain death determination.

Dated July 1, this prospective multicenter observational study assessed how apnea testing methods affect safety and how long the test runs during brain death/DNC determination in adults. It's real prospective data on a step that can make or break your timeline. The findings could inform how hospitals standardize their testing approach.
On your shift: Apnea testing delays or aborted tests stall your entire case - knowing the methodology data helps you anticipate hospital variability and manage the clock on brain death determinations.

Source: PubMed (Organ Donation Research)

2026 OPO Final Rule Compliance
Deadline for OPOs to meet updated CMS performance standards
117 days
OPO Recertification Cycle
2026 performance metrics enforcement deadline
117 days